Trevi Therapeutics

1 follower

‌

Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.

Industries

Biotechnology, Education

Headquarters

New Haven, United States

Employees

11-50

Links

Org chart

Jennifer Good

Co-Founder, President & CEO

Jennifer Good

Collapse

Thomas Sciascia

Co-Founder, Chief Science Officer

Lisa Delfini

CFO

David Clark

Chief Medical Officer

Farrell Simon

Chief Commercial Officer

Katherine Takaki

VP, Global Regulatory Affairs

Katie McManus

Senior Manager, Marketing & Communications

Paula Buckley

VP, Clinical Operations

Pam Nieves

Associate Director, Quality Assurance & Compliance

Teams

Regulatory and Compliance

5 members

Leadership Team

3 members

Medical Affairs and Commercial Strategy

4 members

Clinical Operations

3 members

Finance and Accounting

3 members

Similar companies

Seed Health

4 followers

Education Design Lab

10 followers

Wayfinder

1 follower

Manifold Bio

2 followers

Thermo Fisher Scientific

166 followers

Genentech

150 followers

Biogen

114 followers

Agilent Technologies

63 followers

Guild

33 followers

Babson College

14 followers

Fordham University

13 followers

Explore companies